DATA PLANS
Download historical data for 20 million indicators using your browser.
Subscription Plans
|
Features
API GATEWAY
Direct access to our data from your apps using any programing language.
Features
|
Documentation
Already a user?
Login
Light Mode
Dark Mode
Calendar
News
Markets
Currencies
Stocks
Commodities
Bonds
Crypto
Earnings
Holidays
Indicators
Inflation Rate
Interest Rate
Unemployment Rate
GDP Growth
GDP per Capita
GDP Value
Current Account
Credit Rating
Wages Growth
Gold Reserves
Government Debt
Crude Oil Production
Gasoline Prices
Heatmap Table
More Indicators
Countries
United States
China
Japan
Canada
Australia
Brazil
Russia
India
Euro Area
United Kingdom
Germany
France
Italy
Spain
Switzerland
Singapore
More Countries
Forecasts
Countries
Indicators
Currencies
Stocks
Commodities
Bonds
Crypto
Ultragenyx Pharmaceutical | RARE - Market Capitalization
Chart
Quotes
Financials
1Y
5Y
10Y
25Y
MAX
Chart
Column
Line
Area
Spline
Splinearea
Trend
Average(4)
Histogram
Variance
Mean
Maximum
Minimum
Compare
Export
API
Embed
Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.
Features
Questions?
Contact us
Already a Member?
Login
The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.
API Features
Documentation
Interested?
Click here to contact us
Please Paste this Code in your Website
width
height
Preview
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical reported $3.55B in Market Capitalization this June of 2023, considering the latest stock price and the number of outstanding shares.
Market Capitalization
Change
Date
Acadia Pharmaceuticals
ACAD:US
USD 3.05B
475M
Mar/2023
Agios Pharmaceuticals
AGIO:US
USD 1.28B
267M
Mar/2023
Alnylam Pharmaceuticals
ALNY:US
USD 24.83B
4.41B
Mar/2023
BioCryst Pharmaceuticals
BCRX:US
USD 1.57B
568M
Mar/2023
BioMarin Pharmaceutical
BMRN:US
USD 18.24B
992M
Mar/2023
Bluebird Bio
BLUE:US
USD 338M
236M
Mar/2023
Esperion Therapeutics
ESPR:US
USD 142M
317M
Mar/2023
Immunic Inc.
VTL:US
USD 66M
4M
Mar/2023
Insmed
INSM:US
USD 2.33B
381M
Mar/2023
Ionis Pharmaceuticals
IONS:US
USD 5.11B
253M
Mar/2023
Karyopharm Therapeutics
KPTI:US
USD 443M
58M
Mar/2023
Kyowa Hakko Kirin
4151:JP
JPY 1.56T
72.36B
Mar/2023
MacroGenics
MGNX:US
USD 443M
30M
Mar/2023
Mirati Therapeutics
MRTX:US
USD 2.16B
449M
Mar/2023
Moderna Inc
MRNA:US
USD 59.23B
9.78B
Mar/2023
Neurocrine Biosciences
NBIX:US
USD 9.87B
1.61B
Mar/2023
PTC Therapeutics
PTCT:US
USD 3.59B
841M
Mar/2023
Puma Biotechnology
PBYI:US
USD 144M
50M
Mar/2023
Regeneron Pharmaceuticals
REGN:US
USD 89.83B
11.26B
Mar/2023
Sarepta Therapeutics
SRPT:US
USD 12.84B
1.46B
Mar/2023
Ultragenyx Pharmaceutical
RARE:US
USD 2.82B
432M
Mar/2023
Vertex Pharmaceuticals
VRTX:US
USD 81.16B
7.03B
Mar/2023
Xoma
XOMA:US
USD 242M
31M
Mar/2023
Financials
Stock Price
Assets
Cash and Equivalent
Cost of Sales
Current Assets
Current Liabilities
Debt
EBIT
EBITDA
Employees
EPS Earnings Per Share
Equity Capital and Reserves
Gross Profit on Sales
Interest Income
Loan Capital
Market Capitalization
Net Income
Operating Expenses
Operating Profit
Ordinary Share Capital
Pre-Tax Profit
Sales Revenues
Selling and Administration Expenses
Stock
Trade Creditors
Trade Debtors